STOCK TITAN

Leonardo DRS, Inc. (DRS) Financials

DRS
Trailing 12 months to June 30, 2026
Revenue $3.8B +10.5% YoY
Net Income $322.0M +28.8% YoY
EPS (Diluted) $1.19 +26.6% YoY
Free Cash Flow $363.0M +54.5% YoY
Market Cap $9.8B as of Oct 3, 2026
Price / Sales 2.6x on $3.8B revenue, trailing 12 months to June 30, 2026
Price / Earnings 30.5x on $322.0M net income, trailing 12 months to June 30, 2026
Price / Book 3.5x on $2.8B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DRS SEC filings page.

Leonardo DRS, Inc. (DRS) reported $3.8B in revenue over the twelve months to Jun 30, 2026, up 10.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DRS FY2025

Revenue growth is translating into wider margins and cash generation while debt shrinks, making expansion increasingly self-funded.

The margin step-up from FY2023 to FY2025—operating margin rose from 8.2% to 9.5% while free-cash-flow margin moved from 5.1% to 6.2%—indicates more of the added sales is reaching cash generation rather than being absorbed by operating costs.

Cash conversion is supportive: operating cash flow reached $366M in FY2025 versus net income of $278M, after also exceeding net income in FY2023 and FY2024. That recurring surplus indicates reported earnings are converting into cash rather than depending solely on accounting profitability.

Capital expenditures rose from $60M in FY2023 to $139M in FY2025, yet free cash flow increased from $145M to $227M; reinvestment is expanding without consuming all internally generated cash. Meanwhile, the debt-to-equity ratio declined from 0.2x to 0.1x as equity grew, leaving the balance sheet less reliant on borrowing.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 69 / 100
Financial Health Score 69/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Leonardo DRS, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
73

Leonardo DRS, Inc. has an operating margin of 9.5%, meaning the company retains $10 of operating profit per $100 of revenue. This strong profitability earns a score of 73/100, reflecting efficient cost management and pricing power. This is up from 9.1% the prior year.

Growth
73

Leonardo DRS, Inc.'s revenue grew 12.8% year-over-year to $3.6B, a solid pace of expansion. This earns a growth score of 73/100.

Leverage
95

Leonardo DRS, Inc. carries a low D/E ratio of 0.12, meaning only $0.12 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 95/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
56

Leonardo DRS, Inc.'s current ratio of 1.89 indicates adequate short-term liquidity, earning a score of 56/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
49

Leonardo DRS, Inc. has a free cash flow margin of 6.2%, earning a moderate score of 49/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
65

Leonardo DRS, Inc. earns a strong 10.2% return on equity (ROE), meaning it generates $10 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 65/100. This is up from 8.3% the prior year.

Altman Z-Score Safe
4.00

Leonardo DRS, Inc. scores 4.00, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($9.8B) relative to total liabilities ($1.8B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong
7/9

Leonardo DRS, Inc. passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
1.32x

For every $1 of reported earnings, Leonardo DRS, Inc. generates $1.32 in operating cash flow ($366.0M OCF vs $278.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
43.50x

Leonardo DRS, Inc. earns $43.50 in operating income for every $1 of interest expense ($348.0M vs $8.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$913.0M
YoY+10.1%
QoQ+7.9%
5Y CAGR+6.8%

Leonardo DRS, Inc. generated $913.0M in revenue in Q2 2026. This represents an increase of 10.1% from the same quarter a year earlier. Against the prior quarter it is up 7.9%.

EBITDA
$128.0M
YoY+37.6%
QoQ+26.7%
5Y CAGR+14.5%

Leonardo DRS, Inc.'s EBITDA was $128.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 37.6% from the same quarter a year earlier. Against the prior quarter it is up 26.7%.

Net Income
$86.0M
YoY+59.3%
QoQ+38.7%
5Y CAGR+21.9%

Leonardo DRS, Inc. reported $86.0M in net income in Q2 2026. This represents an increase of 59.3% from the same quarter a year earlier. Against the prior quarter it is up 38.7%.

EPS (Diluted)
$0.32
YoY+60.0%
QoQ+39.1%
5Y CAGR+7.8%

Leonardo DRS, Inc. earned $0.32 per diluted share (EPS) in Q2 2026. This represents an increase of 60.0% from the same quarter a year earlier. Against the prior quarter it is up 39.1%.

Cash & Balance Sheet

Free Cash Flow
$6.0M
YoY+110.7%
QoQ+106.3%
5Y CAGR-34.0%

Leonardo DRS, Inc. generated $6.0M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 110.7% from the same quarter a year earlier. Against the prior quarter it is up 106.3%.

Cash & Debt
$270.0M
YoY-2.9%
QoQ-17.7%
5Y CAGR+24.3%

Leonardo DRS, Inc. held $270.0M in cash against $139.0M in long-term debt as of Q2 2026.

Dividends Per Share
$0.09
YoY0.0%
QoQ0.0%

Leonardo DRS, Inc. paid $0.09 per share in dividends in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
267M
YoY+0.3%
QoQ0.0%
5Y CAGR+13.0%

Leonardo DRS, Inc. had 267M shares outstanding in Q2 2026. This represents an increase of 0.3% from the same quarter a year earlier. It is unchanged from the prior quarter.

Margins & Returns

Gross Margin
26.0%
YoY+2.2pp
QoQ+0.9pp
5Y change+6.7pp

Leonardo DRS, Inc.'s gross margin was 26.0% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 2.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.9 percentage points.

Operating Margin
11.2%
YoY+2.7pp
QoQ+2.1pp
5Y change+3.4pp

Leonardo DRS, Inc.'s operating margin was 11.2% in Q2 2026, reflecting core business profitability. This is up 2.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.1 percentage points.

Net Margin
9.4%
YoY+2.9pp
QoQ+2.1pp
5Y change+4.6pp

Leonardo DRS, Inc.'s net profit margin was 9.4% in Q2 2026, showing the share of revenue converted to profit. This is up 2.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.1 percentage points.

Return on Equity
3.1%
YoY+1.0pp
QoQ+0.8pp
5Y change+0.9pp

Leonardo DRS, Inc.'s ROE was 3.1% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 1.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.8 percentage points.

Capital Allocation

R&D Spending
$36.0M
YoY+20.0%
QoQ+16.1%

Leonardo DRS, Inc. invested $36.0M in research and development in Q2 2026. This represents an increase of 20.0% from the same quarter a year earlier. Against the prior quarter it is up 16.1%.

Share Buybacks
$12.0M
YoY+9.1%
QoQ+200.0%

Leonardo DRS, Inc. spent $12.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 9.1% from the same quarter a year earlier. Against the prior quarter it is up 200.0%.

Capital Expenditures
$29.0M
YoY+3.6%
QoQ-3.3%
5Y CAGR+12.6%

Leonardo DRS, Inc. invested $29.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 3.6% from the same quarter a year earlier. Against the prior quarter it is down 3.3%.

DRS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DRS quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$913.0M+10.1%$846.0M+5.9%$1.1B+8.1%$960.0M+18.2%$829.0M+10.1%$799.0M+16.1%$981.0M+5.9%$812.0M+15.5%
Cost of Revenue$676.0M+7.0%$634.0M+2.6%$791.0M+6.0%$738.0M+16.6%$632.0M+8.2%$618.0M+15.5%$746.0M+4.2%$633.0M+17.0%
Gross Profit$237.0M+20.3%$212.0M+17.1%$269.0M+14.5%$222.0M+24.0%$197.0M+16.6%$181.0M+18.3%$235.0M+11.9%$179.0M+10.5%
R&D Expenses$36.0M+20.0%$31.0M+10.7%$35.0M+25.0%$36.0M+56.5%$30.0M+42.9%$28.0M+40.0%$28.0M$23.0M
SG&A Expenses$129.0M+6.6%$130.0M+11.1%$136.0M+25.9%$123.0M+25.5%$121.0M+13.1%$117.0M+15.8%$108.0M+10.2%$98.0M+2.1%
Operating Income$102.0M+45.7%$77.0M+30.5%$126.0M+5.0%$93.0M+24.0%$70.0M+27.3%$59.0M+37.2%$120.0M+14.3%$75.0M+27.1%
EBITDA$128.0M+37.6%$101.0M+23.2%$150.0M+4.9%$116.0M+18.4%$93.0M+19.2%$82.0M+26.2%$143.0M+12.6%$98.0M+22.5%
Interest ExpenseN/AN/A$1.0M-75.0%$4.0M-20.0%$2.0M-71.4%$1.0M-80.0%$4.0M-55.6%$5.0M-50.0%
Income Tax$14.0M+7.7%$15.0M+87.5%$22.0M0.0%$15.0M+25.0%$13.0M+44.4%$8.0M0.0%$22.0M+4.8%$12.0M+1100.0%
Net Income$86.0M+59.3%$62.0M+24.0%$102.0M+14.6%$72.0M+26.3%$54.0M+42.1%$50.0M+72.4%$89.0M+20.3%$57.0M+21.3%
EPS (Basic)$0.33+65.0%$0.23+21.1%$0.39+14.7%$0.27+22.7%$0.20+42.9%$0.19+72.7%$0.34+21.4%$0.22+22.2%
EPS (Diluted)$0.32+60.0%$0.23+21.1%$0.38+11.8%$0.26+23.8%$0.20+42.9%$0.19+72.7%$0.34+21.4%$0.21+16.7%
Diluted Shares (Avg)269M0.0%269M0.0%N/A268M0.0%269M+0.6%269M+0.9%N/A268M+1.2%

DRS Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DRS quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$4.2B+2.9%$4.2B+2.8%$4.5B+7.2%$4.2B+9.9%$4.1B+6.8%$4.1B+8.3%$4.2B+6.7%$3.9B+4.0%
Current Assets$2.0B+0.7%$2.1B-0.7%$2.3B+7.5%$2.2B+16.5%$2.0B+12.2%$2.1B+16.8%$2.2B+12.8%$1.9B+6.9%
Cash & Equivalents$270.0M-2.9%$328.0M-13.7%$647.0M+8.2%$309.0M+56.1%$278.0M+86.6%$380.0M+137.5%$598.0M+28.1%$198.0M+321.3%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$383.0M-4.3%$371.0M-3.6%$352.0M-1.7%$404.0M+11.3%$400.0M+9.0%$385.0M+12.6%$358.0M+8.8%$363.0M-5.2%
Accounts Receivable$319.0M+20.4%$324.0M+27.6%$334.0M+32.0%$327.0M+38.0%$265.0M+41.0%$254.0M+30.9%$253.0M+67.5%$237.0M+18.5%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$1.2B0.0%$1.2B0.0%$1.2B0.0%$1.2B0.0%$1.2B0.0%$1.2B0.0%$1.2B0.0%$1.2B+0.2%
Total Liabilities$1.4B-5.7%$1.4B-5.5%$1.8B+7.9%$1.6B+15.1%$1.5B+4.7%$1.5B+6.9%$1.6B+1.9%$1.4B-5.7%
Current Liabilities$1.1B+11.2%$1.1B+7.6%$1.2B+10.3%$1.1B+23.0%$958.0M+6.9%$1.0B+13.9%$1.1B+3.5%$880.0M-7.5%
Non-Current Liabilities$329.0M-36.9%$336.0M-32.5%$525.0M+2.7%$515.0M+1.6%$521.0M+0.8%$498.0M-5.0%$511.0M-1.4%$507.0M-2.5%
Long-Term Debt$139.0M-58.0%$140.0M-58.2%$321.0M-5.6%$326.0M-5.5%$331.0M-5.7%$335.0M-5.9%$340.0M-2.6%$345.0M-1.7%
Total Equity$2.8B+7.8%$2.8B+7.7%$2.7B+6.8%$2.6B+7.0%$2.6B+8.1%$2.6B+9.2%$2.6B+10.0%$2.5B+10.3%
Retained Earnings-$2.2B+12.9%-$2.3B+11.4%-$2.3B+10.7%-$2.4B+9.9%-$2.5B+9.1%-$2.5B+8.4%-$2.6B+7.6%-$2.7B+6.9%

DRS Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DRS quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$35.0M+225.0%-$66.0M+52.2%$425.0M-4.1%$107.0M+81.4%-$28.0M-182.4%-$138.0M+47.9%$443.0M-14.0%$59.0M+63.9%
Depreciation & Amortization$26.0M+13.0%$24.0M+4.3%$24.0M+4.3%$23.0M0.0%$23.0M0.0%$23.0M+4.5%$23.0M+4.5%$23.0M+9.5%
Stock-Based CompensationN/A$4.0M-50.0%N/AN/AN/A$8.0M+700.0%N/AN/A
Capital Expenditures$29.0M+3.6%$30.0M-6.3%$49.0M+69.0%$30.0M+150.0%$28.0M-17.6%$32.0M+220.0%$29.0M+61.1%$12.0M-20.0%
Free Cash Flow$6.0M+110.7%-$96.0M+43.5%$376.0M-9.2%$77.0M+63.8%-$56.0M-$170.0M+38.2%$414.0M-16.7%$47.0M+123.8%
Investing Cash Flow-$29.0M-3.6%-$29.0M+9.4%-$49.0M-69.0%-$45.0M-309.1%-$28.0M+17.6%-$32.0M-220.0%-$29.0M-70.6%-$11.0M+31.3%
Financing Cash Flow-$64.0M-39.1%-$224.0M-366.7%-$38.0M-171.4%-$31.0M-3200.0%-$46.0M-318.2%-$48.0M-50.0%-$14.0M+82.1%$1.0M+112.5%
Share Buybacks$12.0M+9.1%$4.0M+33.3%$11.0M$10.0M$11.0M$3.0M$0-100.0%$0

Not reported in any period shown, so not listed: Dividends Paid.

DRS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DRS quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Gross Margin26.0%+2.2pp25.1%+2.4pp25.4%+1.4pp23.1%+1.1pp23.8%+1.3pp22.7%+0.4pp24.0%+1.3pp22.0%-1.0pp
Operating Margin11.2%+2.7pp9.1%+1.7pp11.9%-0.3pp9.7%+0.5pp8.4%+1.1pp7.4%+1.1pp12.2%+0.9pp9.2%+0.8pp
Net Margin9.4%+2.9pp7.3%+1.1pp9.6%+0.5pp7.5%+0.5pp6.5%+1.5pp6.3%+2.0pp9.1%+1.1pp7.0%+0.3pp
Return on Equity3.1%+1.0pp2.2%+0.3pp3.7%+0.3pp2.7%+0.4pp2.1%+0.5pp1.9%+0.7pp3.5%+0.3pp2.3%+0.2pp
Return on Assets2.1%+0.7pp1.5%+0.2pp2.3%+0.1pp1.7%+0.2pp1.3%+0.3pp1.2%+0.5pp2.1%+0.2pp1.5%+0.2pp
Current Ratio1.92-0.2x1.86-0.2x1.890.0x2.00-0.1x2.11+0.1x2.02+0.1x1.94+0.2x2.11+0.3x
Debt-to-Equity0.05-0.1x0.05-0.1x0.120.0x0.120.0x0.130.0x0.130.0x0.130.0x0.140.0x
Asset Turnover0.220.0x0.200.0x0.240.0x0.230.0x0.200.0x0.200.0x0.230.0x0.210.0x
FCF Margin0.7%+7.4pp-11.3%+9.9pp35.5%-6.7pp8.0%+2.2pp-6.8%-6.8pp-21.3%+18.7pp42.2%-11.5pp5.8%+2.8pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Leonardo DRS, Inc. DRS FY2025 $3.6B $278.0M 7.6% $9.8B 69/100
Kratos Defense & Security Solutions, Inc. KTOS FY2025 $1.3B $22.0M 1.6% $8.1B 60/100
AeroVironment, Inc. AVAV FY2026 $2.0B -$265.1M -13.4% $7.2B 55/100
Embraer S.A. ERJ FY2025 $7.6B $359.0M 4.7% $11.8B 45/100
Huntington Ingalls Industries, Inc. HII FY2025 $12.5B $605.0M 4.9% $10.6B 46/100
Textron, Inc. TXT FY2025 $14.8B $921.0M 6.2% $13.3B 23/100

Frequently Asked Questions

What is Leonardo DRS, Inc.'s annual revenue?

Leonardo DRS, Inc. (DRS) reported $3.6B in total revenue for fiscal year 2025. This represents a 12.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Leonardo DRS, Inc.'s revenue growing?

Leonardo DRS, Inc. (DRS) revenue grew by 12.8% year-over-year, from $3.2B to $3.6B in fiscal year 2025.

Is Leonardo DRS, Inc. profitable?

Yes, Leonardo DRS, Inc. (DRS) reported a net income of $278.0M in fiscal year 2025, with a net profit margin of 7.6%.

Leonardo DRS, Inc. (DRS) reported diluted earnings per share of $1.03 for fiscal year 2025. This represents a 28.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Leonardo DRS, Inc. (DRS) had EBITDA of $441.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Leonardo DRS, Inc. (DRS) had $647.0M in cash and equivalents against $321.0M in long-term debt.

Leonardo DRS, Inc. (DRS) had a gross margin of 23.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Leonardo DRS, Inc. (DRS) had an operating margin of 9.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Leonardo DRS, Inc. (DRS) had a net profit margin of 7.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Leonardo DRS, Inc. (DRS) paid $0.36 per share in dividends during fiscal year 2025.

Leonardo DRS, Inc. (DRS) has a return on equity of 10.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Leonardo DRS, Inc. (DRS) generated $227.0M in free cash flow during fiscal year 2025. This represents a 22.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Leonardo DRS, Inc. (DRS) generated $366.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Leonardo DRS, Inc. (DRS) had $4.5B in total assets as of fiscal year 2025, including both current and long-term assets.

Leonardo DRS, Inc. (DRS) invested $139.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Leonardo DRS, Inc. (DRS) invested $129.0M in research and development during fiscal year 2025.

Yes, Leonardo DRS, Inc. (DRS) spent $35.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Leonardo DRS, Inc. (DRS) had 266M shares outstanding as of fiscal year 2025.

Leonardo DRS, Inc. (DRS) had a current ratio of 1.89 as of fiscal year 2025, which is generally considered healthy.

Leonardo DRS, Inc. (DRS) had a debt-to-equity ratio of 0.12 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Leonardo DRS, Inc. (DRS) had a return on assets of 6.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Leonardo DRS, Inc. (DRS) trades at 30.5x earnings, its market capitalization divided by net income of $322.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $9.8B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Leonardo DRS, Inc. (DRS) trades at 2.6x sales, its market capitalization divided by revenue of $3.8B revenue, trailing 12 months to June 30, 2026. The market capitalization is $9.8B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Leonardo DRS, Inc. (DRS) has an Altman Z-Score of 4.00, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Leonardo DRS, Inc. (DRS) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Leonardo DRS, Inc. (DRS) has an earnings quality ratio of 1.32x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Leonardo DRS, Inc. (DRS) has an interest coverage ratio of 43.50x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Leonardo DRS, Inc. (DRS) scores 69 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top